Ubs Global Asset Management Americas »

Mirum Pharmaceuticals shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 41k 29.52
2023-09-30 $1.2M 39k 31.60
2023-06-30 $549k 23k 24.02
2023-03-31 $549k 23k 24.02
2022-12-31 $393k 20k 19.50

More positions owned by Ubs Global Asset Management Americas

Microsoft Corp Equity Us Cm (MSFT)
Apple Equity Us Cm (AAPL)
Amazon Equity Us Cm (AMZN)
Nvidia Corp Equity Us Cm (NVDA)
Alphabet Inc Cl A Equity Us Cm (GOOGL)
Tesla Equity Us Cm (TSLA)
Meta Platforms Equity Us Cm (META)
Alphabet Inc Cl C Equity Us Cm (GOOG)
Unitedhealth Group Equity Us Cm (UNH)
Broadcom Equity Us Cm (AVGO)
Adobe Equity Us Cm (ADBE)
Eli Lilly &#38 Equity Us Cm (LLY)
Visa Inc Class A Shares Equity Us Cm (V)
Home Depot Equity Us Cm (HD)
Johnson &#38 Johnson Equity Us Cm (JNJ)

View all positions for Ubs Global Asset Management Americas

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
BVF
Eventide Asset Management
Vanguard Group
Henderson Group
Cadian Capital Management
Citadel Advisors
T. Rowe Price Associates
Avidity Partners Management
Tang Capital Management
Franklin Resources
First Turn Management
William Blair Investment Management
Perceptive Advisors
Boone Capital Management

View all funds holding Mirum Pharmaceuticals